An intervention to reduce sedentary behavior for adults with chronic kidney disease: RESET-CKD.
- Institution
- UNIVERSITY OF ILLINOIS AT CHICAGO, IL
- Principal investigator
- Mary Hannan
- Funding
- $173K
- Duration
- 2024–2027
Moonbase score
Still being scored
Abstract
The purpose of this K23 Mentored Patient-Oriented Career Development Award application is to support the applicant’s long-term goal to develop an independent research program focused on improving the health and quality of life for adults with chronic kidney disease (CKD) through healthy lifestyle behaviors. Adults with CKD are extremely sedentary, and the poor health outcomes associated with CKD may be modifiable by addressing sedentary behavior- a lifestyle behavior associated with adverse health consequences. Black adults are disproportionately affected by CKD and have some of the worst health outcomes among those with CKD. Theory-based behavioral interventions can effectively reduce sedentary time, but research is lacking on theory-based sedentary reducing interventions adapted to meet the unique needs of the at-risk population of adults of with CKD. The overall goal of this award is to adapt an evidenced-based intervention to reduce sedentary time for adults with CKD guided by patient-centered design. During Aim 1, an evidenced-based sedentary reducing intervention will be adapted to address unique factors that influence sedentary behavior for those with CKD. Adaptation of the intervention will be led by a Patient Advisory Board comprised of Black adults with CKD. In Aim 2, we will conduct a 12-week pilot randomized controlled trial of the adapted intervention (RESET-CKD) to reduce sedentary time for Black adults with CKD. In Aim 3, we will explore the lived experience of the RESET-CKD intervention participants and identify barriers and facilitators to reducing sedentary time. These findings will be used to inform the development of the efficacy trial that will follow this K23 award. Under the guidance of the multidisciplinary mentoring team, the applicant will receive training in clinical trial design and mixed methods to conduct this innovative work and expand the applicant’s program of research. Completion of this proposal will generate data to support an R01 application to conduct a large, randomized controlled intervention to decrease sedentary time and improve outcomes in adults with CKD. This K23 Award will support the candidate’s career development as a nurse scientist by conducting mentored research focused on decreasing sedentary behavior for adults with CKD.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF ILLINOIS AT CHICAGO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Illinois at Chicago47
MASLD protection by STAT5-regulated transcription factors
Rhonda D Kineman · $825K · 2025–2030
- NIH · University of Illinois at Chicago47
Identifying a novel pathway that regulates RA immunometabolism
Shiva Shahrara · $715K · 2022–2028
- NIH · University of Illinois at Chicago45
Precise Combination Strategies Targeting Carbapenem-Resistant Klebsiella pneumoniae
Zackery P. Bulman · $720K · 2022–2027